AIMCA
ITOS

Alberta Investment Management Corp (AIMCo)’s iTeos Therapeutics ITOS Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,099
Closed -$490K – 1276
2022
Q4 		$490K Buy
25,099
+11,254
+81% +$220K ﹤0.01% 924
2022
Q3 		$264K Sell
13,845
-6,840
-33% -$158K ﹤0.01% 1136
2022
Q2 		$426K Buy
20,685
+3,908
+23% +$92.7K ﹤0.01% 1079
2022
Q1 		$540K Hold
16,777
– – ﹤0.01% 1093
2021
Q4 		$781K Buy
+16,777
New +$558K ﹤0.01% 817

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ITOS Position: Q1 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of iTeos Therapeutics (ITOS) in Q1 2023, closing a stake of 25,099 shares — an estimated $490K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ITOS in Q4 2021 and held it in 5 quarters. The position peaked at $781K in Q4 2021. 153 funds tracked by Wall St. Rank hold ITOS as of Q1 2023.

  • Alberta Investment Management Corp (AIMCo) reported no remaining iTeos Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 25,099 iTeos Therapeutics shares in Q1 2023, an estimated $490K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in iTeos Therapeutics in Q4 2021 and held it in 5 quarters.
  • Alberta Investment Management Corp (AIMCo)'s iTeos Therapeutics position peaked at $781K in Q4 2021.
  • 153 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q1 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2023, filed 15 May 2023.